Hide M, Park H-S, Igarashi A, Ye Y-M, Kim T-B, Yagami A. Efficacy and Safety of Omalizumab in Japanese and Korean Patients with Chronic Idopathic/Spontaneous Urticaria (CIU/CSU: Results from the Phase 3 POLARIS Study. J of Skin [Internet]. 2017 Oct. 27 [cited 2024 Jul. 23];1(3.1):s126. Available from: https://jofskin.org/33014/index.php/skin/article/view/185